China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients ...

Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

United Airlines has purchased all the capacity on a northbound cargo service from Puerto Rico to Chicago operated by Global ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners, investors and others to step up and support the sector.

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...

Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

Cathie Wood says most profound application of AI is in healthcare. She particularly expects Recursion Pharma and Illumina to ...